Bone Marrow Transplantation News

Patients with beta-thalassemia who underwent hematopoietic stem cell transplantation experienced similar long-term quality of life as individuals in the general population, according to study results.

Patients with acute myelogenous leukemia in first remission treated with cyclophosphamide plus busulfan experienced longer leukemia-free survival and OS than those treated with cyclophosphamide plus total body irradiation, according to results of a retrospective study.

Patients with acute myelogenous leukemia in first remission treated with cyclophosphamide plus busulfan experienced longer leukemia-free survival and OS than those treated with cyclophosphamide plus total body irradiation, according to results of a retrospective study.

Use of a multidisciplinary central line maintenance care bundle significantly reduced central line–associated bloodstream infections and bacteremias in an ambulatory pediatric cancer patients, according to study results.

Rituximab prophylaxis considerably reduced corticosteroid-requiring chronic graft-vs.-host disease in patients who underwent allogeneic peripheral blood stem cell transplantation, according to results of a prospective, open-label, phase 2 study.

Patients who underwent hematopoietic stem cell transplantation were less likely to contract cytomegalovirus disease when treated with higher doses of CMX001, according to results of a randomized study.

Improvements in risk stratification to predict treatment-resistant acute graft-versus-host disease and mortality without relapse were observed when suppression of tumorigenicity 2 levels were measured at therapy initiation and within the first month after stem cell transplantation, according to recent study findings.

Improvements in risk stratification to predict treatment-resistant acute graft-versus-host disease and mortality without relapse were observed when suppression of tumorigenicity 2 levels were measured at therapy initiation and within the first month after stem cell transplantation, according to recent study findings.

Vaccination with whole leukemia cells shortly after allogeneic hematopoietic stem cell transplantation was associated with increased long-term disease control in a cohort of patients with chronic lymphocytic leukemia, according to results of a prospective trial.

Allogeneic hematopoietic stem cell transplantation considerably improved the prognosis of patients with acute lymphoblastic leukemia who demonstrated unsatisfactory reduction of minimal residual disease after induction therapy and were at intermediate risk for relapse, according to study results.